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Transparent Polyurethane Film as
an Intravenous Catheter Dressing
A Meta-analysis of the Infection Risks
Karen K. Hoffmann, MS; David J. Weber, MD, MPH; Gregory P. Samsa, PhD; William A. Rutala, PhD, MPH
Objective.\p=m-\Toobtain a quantitative estimate of the impact on infectious com-
plications of using transparent dressings with intravenous catheters.
Data Sources.\p=m-\Meta-analysisof all studies published in the English literature,
including abstracts, letters, and reports that examined the primary research ques-
tion of infection risks associated with transparent compared with gauze dressings
for use on central and peripheral venous catheters. Studies were identified by use
of the MEDLINE database using the indexing terms occlusive dressings, trans-
parent dressings, and infection and by review of referenced bibliographies.
Study Selection.\p=m-\Sevenof the 15 studies (47%) of central venous catheters
and seven of 12 studies (58%) of peripheral catheters met our inclusion criteria for
analysis. All studies used a prospective cohort design, utilized hospitalized patients,
and reported at least one of our defined outcomes.
Extraction.\p=m-\Datafor each study were abstracted independently by three
investigators. At least three studies were used in the analysis of each outcome.
Data Synthesis.\p=m-\Applyinga Mantel-Haenszel \g=x\2 analysis, use of transparent
dressings on central venous catheters was significantly associated with an elevated
relative risk (RR) of catheter tip infection (RR = 1.78; 95% confidence interval [CI],
1.38 to 2.30). Catheter-related sepsis (RR = 1.69; 95% CI, 0.97 to 2.95) and bac-
teremia (RR = 1.63; 95% CI, 0.76 to 3.47) were both associated with an elevated
RR. Use of transparent dressings on peripheral catheters was associated with an
elevated RR of catheter-tip infection (RR=1.53; 95% CI, 1.18 to 1.99) but not
phlebitis (RR = 1.02; 95% CI, 0.86 to 1.20), infiltration (RR = 1.12; 95% CI, 0.92 to
1.37), or skin colonization (RR =0.99; 95% CI, 0.90 to 1.09).
Conclusion.\p=m-\Theresults demonstrated a significantly increased risk of
catheter-tip infection with the use of transparent compared with gauze dressings
when used with either central or peripheral catheters. An increased risk of bacte-
remia and catheter sepsis associated with the use of transparent compared with
gauze dressings for use on central venous catheters was suggested.
(JAMA. 1992;267:2072-2076)
MOST hospitalized patients receive pe¬
ripheral infusion therapy via a periph¬
eral venous catheter for administration
of fluids and electrolytes, nutrition, and
medications. Complications of periph-
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eral catheterization may include phle¬
bitis, cellulitis, and sepsis. Factors asso¬
ciated with infection are placement for
longer than 72 hours, plastic vs steel cath¬
eter, cutdown vs percutaneous place¬
ment, and skill of the venipuncturist.
Central venous catheters are increas¬
ingly used to allow hemodynamic mon¬
itoring, provide total parenteral nutri¬
tion, and administer medications that
require instillation into a central vein.
Once central venous catheters are in¬
serted correctly, the major complica¬
tion is infection. ' Factors associated with
an increased risk of central catheter in¬
fection include severity of underlying
illness, multiple vs single lumen, use of
catheter for total parenteral nutrition,
and placement of the catheter in the
femoral site compared with jugular-sub-
clavian placement.2 Other risk factors
include frequency of dressing changes,
method of disinfection of skin prior to
catheter insertion, use of antibacterial
ointment at the insertion site, frequency
of catheter replacement, and type of
catheter dressing material.3
Transparent dressings made of a thin,
semipermeable polyurethane material
are widely used on central and periph¬
eral venous catheters because they al¬
low inspection of the insertion site and
provide an occlusive dressing. Fourteen
randomized prospective studies have as¬
sessed at least one infection outcome
associated with use oftransparent dress¬
ings on central410 or peripheral11"17
venous catheters but have reported in¬
conclusive results in part because of
small numbers of patients. This meta-
analysis was undertaken to give an over¬
all quantitative assessment of risk of
transparent dressings for use on central
and peripheral venous catheters.18,19
METHODS
Selection of Studies
We attempted to locate all research ar¬
ticles, abstracts, or letters published in
the English language medical literature
examining infectious complications asso¬
ciated with use of transparent dressings
on venous catheters by scanning the
MEDLINE Search Computer Retrieval
Service from 1966 through the middle of
1991 using the key words occlusive dress¬
ings or transparent dressings, under the
heading wound infections. All references
cited in published works were investi¬
gated to detect additional studies. Data in
abstract formwere included in an attempt
to avoid publication bias.20 The existence
of publication bias, whereby research
with statistically significant results is
more likely to be submitted and published
than research with null or nonsignificant
results,.has been documented.21
We required a prospective randomized
cohort design (or its equivalent) using
hospitalized patients. An exception was
Table 1.—Comparison of Studies Evaluating Transparent vs Gauze Dressings for Central Venous Catheters*
Powell et al4 Maki and Will7 Powell et al8 Maki and Will"'
Andersen
et al5 Young et al9 Conly et al6
Study design
Cohort-prospective Yes Yes Yes Yes Yes Yes
Random assignment
to treatment group Yes Yes Yes Yes Yes Yes Yes
Study size
No. of cases (TD) 123 225 262 60 132
No. of controls (GD) 138 148 111 105 75 36 34
Study method
Ointment










TD brand Opsite Tegaderm Opsite Opsite Opsite Opsite Opsite
Duration, dressing
changes
TD Every 7 d Every 2 d,
every 7 d
3 times/wk Every 5 d Indefinite 2 times/wk, every Every 2 d
7 d, every 10 d
GD 3 times/wk Every 2 d 3 times/wk,
every 7 d
Every 2d Indefinite 3 times/wk Every 2 d
Duration of catheters,
mean days
TD 24 19.3-23.5 5.2 13.3-14.9 17.9
GD 22 20.3 13.1 13.5












No. with outcome (%)
TD 11/123(8.9) 76/225 (33.8) 5/262 (1.9) 15/60(25) 26/42 (61.9)
GD 4/138(2.9) 37/148(25) 2/111 (1.8) 5/75 (6.7) 8/34 (23.5)
RR 3.09 1.35 1.06 3.75 2.63
95% CI 1.01-9.44 0.97-1.89 0.21-5.38 1.45-9.73 1.37-5.04
.06 .08 .003 .0001
Bacteremia
No. with outcome (%)
TD 15/262(5.7) 3/60 (5) 12/132(9.1)
GD 3/111 (2.7) 2/75 (2.7) 3/36 (8.3)
RR 2.12 1.1 1.09
95% CI 0.63-7.17 0.32-10.86 0.33-3.66
1.0
Catheter sepsis
No. with outcome (%)
TD 6/123(4.9) 8/225 (3.6) 8/262(3.1) 4/93 (4.3) 2/60 (3.3) 2/132(1.5) 7/42(16.7)
GD 1/138(0.7) 5/148(3.4) 5/111 (4.5) 2/105 (1.9) 1/75(1.3) 1/36(2.8) 0/34 (0)
RR 6.73 1.05 0.68 2.26 2.50 0.55
95% CI 0.82-55.14 0.35-3.16 0.23-2.03 0.42-12.05 0.23-26.91 0.05-5.85
.04 .01
*TD indicates transparent dressings; GD, gauze dressings; TPN, total parenteral nutrition; RR, relative risk; and CI, confidence interval.
tMixed indicates TPN, chemotherapy, and hemodynamic monitoring.
Young et al,9 who used different hospital
floors with a similar patient population as
evidenced by similarparameters (eg, age,
sex, septicemia, and open septic drain¬
age) as their mechanism of randomiza¬
tion. Kelsey and Gosling11 used different
dressing materials on patients admitted
to the same medical units at different
times. Case reports, editorials, and re¬
views that did not provide primary data
were excluded. Eight studies of central
venous catheters were excluded from
analysis because the study was not pro¬
spective22 or comparative23,24; allocation to
treatment group was not randomized23;
primary data were not provided25"27; out¬
come variables were not adequately de¬
fined24·25,27; subcutaneously tunneled
catheters were used28; and paper tape was
used forcontrol dressing.29 Five studies of
peripheral venous catheters were ex¬
cluded because the study was not pro¬
spective30,31 orcomparative32; allocationto
treatment groups was not random¬
ized30,33,34; and primary data were not pro¬
vided.30,34 Use of these rigid criteria al¬
lowed selection of a group of studies com¬
parable with regard to the central
research question, study design, and pre¬
dictor and outcome measures.
Data Analysis
As outcome measures in each study
were proportions (eg, the proportion of
control subjects with catheter sepsis), a
Mantel-Haenszel  2 analysis was per¬
formed. Risk ratios (ie, outcome rate in
the transparent dressing group divided
by the outcome rate in the control group)
were calculated for each study, and the
Breslow-Day statistic was used to as¬
sess their heterogeneity.35 The Breslow-
Day test may have relatively low power
in this application, ie, only extreme de¬
partures from homogeneous risk ratios
are likely to be flagged as statistically
significant. Under the assumption of ho¬
mogeneous risk, the Mantel-Haenszel
method was used to estimate a summary
measure of effect, its confidence interval
(CI), and to test its significance. Although
this measure is most interpretable when
the Breslow-Day test for interaction is
nonsignificant, we also considered it if an
interaction was present, but all individual
studies demonstrated relative risks
(RRs) greater than unity.36 At least three
studies were analyzed for each outcome.
Outcome Definitions
Data on complications were abstracted
from studies that used central venous
catheters (catheter-tip infection, bacte-
remia, and catheter sepsis) and periph¬
eral venous catheters (phlebitis, infil¬
tration, skin colonization, and catheter-
tip infection). Data for each study were
abstracted independently by three ofus
(K.K.H., D.J.W., and W.A.R.) using
the defined outcome definitions. Cath¬
eter-tip infection was defined by a pos¬
itive catheter-tip culture ofgreater than
15 colony-forming units using the method
of Maki et al,37 bacteremia by positive
blood cultures drawn from a peripheral
site or through a central line, and cath¬
eter sepsis by positive blood samples
and catheter-tip cultures that yielded
organisms of the same species. The two
studies by Powell et al4,8 defined cath¬
eter-tip infection by the semiquantita¬
tive culture technique of Maki et al (C.
Powell, RN, oral communication, Feb¬
ruary 28, 1991) and, hence, the data
were included. Young et al9 did not use
the semiquantitative technique (D. Rus¬
sell, MD, oral communication, Febru¬
ary 21, 1991) so their data were excluded.
RESULTS
Central Intravenous Catheters
All seven évaluable studies were pub¬
lished between 1982 and 1989; five
were published in peer-reviewed jour¬
nals,46,8,9 and two were abstracts7,10
(Table 1). Factors that varied among
studies included location of the central
venous catheter, clinical use of the cath¬
eter, regimen for dressing changes, pa¬
tient population, and use and type of
topical antiseptics. The arms of each
study were comparable. Antiseptic oint¬
ment was used in four studies4'5,8,10; in
one study, it was used only under gauze
dressings.4
Several studies reported a statisti¬
cally significant higher infection risk with
use of transparent dressings; three of
five studies reported an increased risk
ofcatheter-tip infection,46 zero of three
an increased risk of bacteremia,5,8,9 and
two of seven an increased risk of cath¬
eter sepsis4,6 (Table 1). However, an in-
Table 2. —Infection Risks of Transparent vs Gauze Dressings Used on Central Venous Catheters
Statistical Test Catheter-Tip Infection Bacteremia Catheter Sepsis
Sample size





Interaction .075 .745 .106
creased RR was shown for all outcomes
of catheter-tip infection (RR of 1.06 to
3.75) and bacteremia (RR of 1.09 to 2.12).
In no case did a study report a signifi¬
cantly increased risk of infection asso¬
ciated with gauze dressings.
Combining these studies yielded more
than 1200 subjects for the evaluation of
catheter-tip infection and catheter sep¬
sis and more than 650 subjects for the
evaluation of bacteremia. Study results
were generally comparable: the point
estimate of the RR exceeded unity for
all catheter-tip and bacteremia studies,
and the Breslow-Day test indicated rel¬
ative homogeneity among outcome mea¬
sures (P>.05). The statistically signifi¬
cant RR for catheter-tip infection was
1.78 (95% CI, 1.38 to 2.30; P<.001), and
catheter sepsis approached statistical sig¬
nificance (RR = 1.69; 95% CI, 0.97 to 2.95;
 =.06). The RR for bacteremia was of
the same order of magnitude (RR = 1.63;
95% CI, 0.76 to 3.47; P= .2) but was not
statistically significant (Table 2).
Peripheral Venous Catheters
The seven évaluable studies were pub¬
lished between 1984 and 1989; six were
published in peer-reviewed jour¬
nals,11,12'14'17 and one appeared as an ab¬
stract.13 Factors that varied among the
studies included type of transparent
dressing, insertion personnel, use and
type of antibacterial ointment, and du¬
ration of transparent and gauze dress¬
ings. Five brands of transparent dress¬
ing materials were used (Table 3). An¬
tibacterial iodophor was used in one
study, only under the gauze dressing.12
In all studies, transparent dressings re¬
mained in place for the lifetime of the
catheter, and gauze dressings were rou¬
tinely changed in all but two studies.11,15
Catheters were replaced routinely in all
studies at 48 to 72 hours, except for one
in which 23% of the catheters remained
in place for 72 hours or longer.15
The likelihood of catheter-tip infec¬
tion was determined in four stud¬
ies13'15·17 (Table 3). Only one study showed
a significant risk associated with the use
of transparent dressings.13 However, all
studies showed a positive RR, which
varied between 1.23 and 4.09.
The risks of phlebitis and infiltration
were assessed in five studies11,12,15"17 and
the risk ofskin colonization in three.14·15·17
No study demonstrated a statistically
significant risk, except for one that re¬
ported a high risk of phlebitis in pa¬
tients with gauze dressings.12
Combining these seven studies that
met our inclusion criteria yielded over
1800 subjects for all outcome measures
(Table 4). A consistent risk (interaction
term, P>.05) was demonstrated for
catheter-tip infection, with an RR of
1.53(95%CI, 1.18to 1.99;P=.002). No
significant overall effect was demon¬
strated between transparent and gauze
dressings for phlebitis, infiltration, and
skin colonization. Point estimates of the
RR were on both sides of unity, even to
the point of a statistically significant in¬
teraction for phlebitis.
COMMENT
Determining the risk factors associ¬
ated with catheter-related sepsis is an
important step in minimizing nosocomial
bacteremia since bacteremia results in
significant morbidity and increased
costs." The RRs calculated by our meta-
analysis represent the best estimates of
the additional infection risks associated
with the use of transparent compared
with gauze dressings. For central venous
catheters, all three outcome measures
demonstrated RRs between 1.63 and
1.78. For catheter-tip infection, the RR
of 1.78 was statistically significant
(P<.001). For bacteremia (RR = 1.63;
 =.2) and catheter-related sepsis
(RR = 1.69; P= .06), the results did not
reach statistical significance, but the
trend suggests that transparent dress¬
ings adversely effect the risk of infec¬
tion. Our data suggest that use of trans¬
parent dressings leads to an increased
risk of bacteremia and sepsis. First, it
has been well described in the literature
that catheter-tip infection is an excel¬
lent harbinger of bacteremia and sep¬
sis.38 Second, for central venous cathe¬
ters, the RRs determined in the meta-
analysis for catheter-tip infection, bac¬
teremia, and catheter-related sepsis
were consistent in demonstrating an in¬
creased risk with the use of transparent
dressings, with a range of 63% to 78%.
For peripheral venous catheters, the
















Cohort-prospective Yes Yes Yes Yes Yes Yes Yes
Random assignment to
treatment group Yes No Yes Yes Yes Yes Yes
Study size
No. of cases (TD) 148 369 152 316 1025 202 300
No. of controls (GD) 136 292 207 421 1063 99 298
Study method
Ointment
TD None None None None lodophort None None
GD lodophor None None None None None None





TD Indefinite Indefinite Indefinite Indefinite Indefinite Indefinite Indefinite
GD Every 1 d Indefinite Not stated Every 1 d
Indefinite,
every 2 d Every 1 d Every 1 d
Duration of catheters,
mean
TD Every 3 d 2.6 d Every 3 d Every 2 d 52 h, 52 h 39 h, 32 h Every 2-3 d
GD Every 3 d 2.6 d Every 3 d Every 2 d 54 h, 55 h 47 h Every 2-3 d
Insertion team IV team Staff IV team IV team Staff IV team IV team





No. with outcome (%)
TD 21/152(13.8) 28/316(8.9) 58/1025(5.7) 14/246(5.7)
GD 7/207 (3.4) 24/421 (5.7) 49/1063(4.6) 10/224(4.4)
RR 4.09 1.55 1.23 1.39
95% CI 1.78-9.36 0.92-2.63 0.85-1.78 0.63-3.07
<.001
Phlebitis
No. with outcome (%)
TD 78/255 (30.6) 50/369(13.5) 97/1025(9.5) 33/202(16.3) 24/246 (9.8)
GD 58/270(21.5) 29/292 (9.9) 100/1063(9.4) 8/99 (8) 17/224(7.6)
RR 0.70 1.36 1.01 2.02 1.29




TD 46/270(17.0) 23/369 (6.2) 69/1025(6.7) 52/202 (25.7) 12/300(4)
GD 32/255(12.5) 24/292 (8.2) 68/1063(6.4) 17/99(17.2) 13/298 (4.5)
RR 1.36 0.758 1.05 1.50 0.92




TD 34/217(15.7) 427/1025(41.7) 53/246 (21.5)
GD 37/286(12.9) 470/1063(44.2) 39/224(17.4)
RR 1.21 0.94 1.35
95% CI 0.79-1.86 0.93-1.96
*TD indicates transparent dressings; GD, gauze dressings; IV, intravenous; RR, relative risk; and CI, confidence interval.
tRefers to iodophor impregnated transparent dressing.
meta-analysis demonstrated a 53% in
creased riskofcatheter-tip infection asso¬
ciated with the use of transparent dress¬
ings. It has been demonstrated that in
most cases, bacterial contamination ofpe¬
ripheral venous catheters results from
colonization of the outer surface of the
catheterby cutaneous flora. Catheter col¬
onization may then lead to bacteremia or
septic thrombophlebitis. While it should
not be assumed that transparent dress







Cases 1739 2112 2166 1488
Controls 1935 1933 1593
Relative risk 1.53 1.02 0.99






ings would be associated with a 53% in¬
crease in bacteremia, it is likely that
higher rates of catheter-tip infection will
result in an elevated rate of bacteremia.
The noninfectious complications ofphlebi¬
tis and infiltration were similar regard¬
less of the dressing material used.
The mechanism by which transparent
dressings increase catheter-associated
infection is likely the promotion of bac¬
terial growth,39 which may be related to
the inadequate moisture vapor perme¬
ability.14 For example, Maki and Will7
reported that the mean log of bacteria
under dressings (ie, colonization of skin)
was significantly greater under trans¬
parent dressings left for 2 and 7 days
(P<.01) compared with gauze dressings
changed every 2 days.7
Several covariates that may affect the
infection risks associated with venous
catheterization including the duration
of catheter use, frequency of dressing
changes, and use ofantiseptic ointment,
are potential confounders in the meta-
analysis. In all studies, duration of cath¬
eter use was similar for both dressing
groups, eliminating this covariate as an
explanation for our results. In several
studies, gauze dressings were changed
more frequently than transparent ones.
Changing transparent dressings more
frequently would significantly increase
the cost of maintaining an intravenous
line since the cost associated with trans¬
parent dressings is approximately three
times that of gauze dressings,17 and the
preparation and dressing time are ap¬
proximately the same, averaging some¬
what less than 4 minutes.7 Similarly, the
results of the meta-analysis may have
been confounded by the differential use of
topical antibacterial agents. Although
topical antiseptic ointments were used
more often with gauze than transparent
dressings, the preferential use was small
compared with the total number of pa¬
tients studied. Further, the use of anti¬
bacterial ointment on transparent dress¬
ings may impair the abilityofthis material
to adhere to skin, and it obscures the en¬
try site, thereby negating two potential
advantages for the use of transparent
dressings.
In a study of 865 catheters, Richet et
al40 analyzed several risk factors for in¬
fection, including site of insertion, type
of dressing, antiseptic use, duration of
catheterization, and purpose of cannula.
A logistic regression analysis revealed
that catheter-tip infection was indepen¬
dently associated with use of transpar¬
ent dressings, duration of catheteriza¬
tion, and jugular insertion site.40
Based on our data, we suggest that the
increased infection risks associated with
transparent dressings be considered in in¬
stitutional decisions regarding their use
until a large, well-controlled study dem¬
onstrates similar infection risks between
gauze and transparent dressings. New,
more permeable dressings may result in
reducing the infection risks associated
with this type of dressing.
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